
Filter News
Area of Research
- (-) Materials (41)
- (-) Nuclear Systems Modeling, Simulation and Validation (1)
- (-) Supercomputing (62)
- Advanced Manufacturing (4)
- Biological Systems (1)
- Biology and Environment (34)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (7)
- Electricity and Smart Grid (3)
- Energy Science (62)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (29)
- Fusion Energy (10)
- Isotope Development and Production (1)
- Isotopes (28)
- Materials for Computing (4)
- Mathematics (1)
- National Security (25)
- Neutron Science (22)
- Nuclear Science and Technology (38)
- Quantum information Science (1)
- Sensors and Controls (1)
News Topics
- (-) Biomedical (22)
- (-) Exascale Computing (26)
- (-) Grid (9)
- (-) Isotopes (14)
- (-) Machine Learning (15)
- (-) Mathematics (2)
- (-) Nuclear Energy (21)
- (-) Space Exploration (5)
- 3-D Printing/Advanced Manufacturing (26)
- Advanced Reactors (6)
- Artificial Intelligence (39)
- Big Data (22)
- Bioenergy (18)
- Biology (14)
- Biotechnology (2)
- Buildings (8)
- Chemical Sciences (32)
- Clean Water (3)
- Composites (9)
- Computer Science (99)
- Coronavirus (17)
- Critical Materials (15)
- Cybersecurity (8)
- Energy Storage (37)
- Environment (35)
- Frontier (32)
- Fusion (8)
- High-Performance Computing (45)
- Irradiation (1)
- ITER (1)
- Materials (79)
- Materials Science (83)
- Microscopy (29)
- Molten Salt (3)
- Nanotechnology (42)
- National Security (8)
- Neutron Science (42)
- Partnerships (11)
- Physics (34)
- Polymers (18)
- Quantum Computing (21)
- Quantum Science (33)
- Security (7)
- Simulation (16)
- Software (1)
- Summit (43)
- Transportation (19)
Media Contacts

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

The Department of Energy’s Oak Ridge National Laboratory has licensed its award-winning artificial intelligence software system, the Multinode Evolutionary Neural Networks for Deep Learning, to General Motors for use in vehicle technology and design.

On Feb. 18, the world will be watching as NASA’s Perseverance rover makes its final descent into Jezero Crater on the surface of Mars. Mars 2020 is the first NASA mission that uses plutonium-238 produced at the Department of Energy’s Oak Ridge National Laboratory.

Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.

Researchers at Oak Ridge National Laboratory are developing a first-of-a-kind toolkit drawing on video game development software to visualize radiation data.

A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.

Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.

About 60 years ago, scientists discovered that a certain rare earth metal-hydrogen mixture, yttrium, could be the ideal moderator to go inside small, gas-cooled nuclear reactors.

ORNL researchers have developed an intelligent power electronic inverter platform that can connect locally sited energy resources such as solar panels, energy storage and electric vehicles and smoothly interact with the utility power grid.

A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.